{
  "id": 7344719,
  "title": "GSK heads to FDA with recently acquired drug from Nuvalent",
  "url": "https://urgent.news/2026/09/14/gsk-heads-to-fda-with-recently-acquired-drug-from-nuvalent",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T15:21:55.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/gsk-heads-to-fda-with-recently-acquired-drug-from-nuvalent/"
  },
  "original_language": "en",
  "account": null,
  "summary": "GSK’s Jideytro posted an impressive response rate of 94% in a first-line treatment for ROS1-positive non-small cell lung cancer patients, according to results shared at the World Conference on Lung Cancer over the weekend. GSK ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}